Some Women With HIV Struggling to Achieve Viral Suppression
A considerable proportion of women with HIV have a high probability of viremia above 200 copies/mL.
Women’s Health
Prophylactic Antibiotic Cuts Infection Risk After Operative Vaginal Birth
A single dose of a prophylactic antibiotic is beneficial after operative vaginal birth and reduces the risk for confirmed or suspected maternal infection.
Feminizing Hormone Therapy May Reduce PrEP Efficacy
In transgender women with HIV, feminizing hormone therapy may decrease the efficacy of pre-exposure prophylaxis.
Recommendations for the Evaluation, Management of Recurrent UTI in Women Released
A new clinical guideline on the diagnosis and treatment of recurrent urinary tract infections in women was released by AUA.
Longer Duration of Antibiotic Use Tied to Risk for CVD in Women
For women in middle and late adulthood, longer duration of antibiotic use is associated with an increased risk for CVD events.
No Significant Effect on Maternal/Fetal Bone Mineral Density With Maternal TDF Use
There was no significant effect of maternal tenofovir use for the prevention of mother-to-child transmission of HBV on bone mineral density in either the mother or child 1 year after delivery.
Dolutegravir-Based Strategies Offer Benefits for Women With HIV
Dolutegravir-based antiretroviral therapy may lead to both fewer deaths in women and fewer overall HIV transmissions.
Dolutegravir Feasible for HIV Treatment in Women of Childbearing Age
Dolutegravir should be considered for ART in treating HIV in women of childbearing potential.
Mycoplasma Genitalium Prevalence in South African Women With HIV
Prevalence of Mycoplasma genitalium in women living with HIV in Johannesburg, South Africa was 7.4%.
Sequelae of Congenital Cytomegalovirus Risk Limited to First Trimester
Congenital cytomegalovirus infection may be severe only when the virus affects the fetus in the embryonic period.
- Loading...
Loading...
Next post in Pediatric Illnesses
Loading... 
Loading...